Pathologic Complete Response to Neoadjuvant Chemotherapy Plus Trastuzumab Predicts for Improved Survival in Women With HER2-positive Breast Cancer

✍ Scribed by Kim, M.M.; Allen, P.; Gonzalez-Angulo, A.; Woodward, W.A.; Meric-Bernstam, F.; Buzdar, A.U.; Hunt, K.K.; Hortobagyi, G.N.; Buchholz, T.A.; Mittendorf, E.A.

• Book ID: 122019090
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 54 KB
• Volume: 84
• Category: Article
• ISSN: 0360-3016
• DOI: 10.1016/j.ijrobp.2012.07.594